Characterization of alpha1-adrenoceptor subtypes in facilitation of rat spinal motoneuron activity

European Journal of Pharmacology
T WadaH Ono

Abstract

The subtypes of alpha1-adrenoceptor mediating facilitation of alpha-motoneuron activity in adult rat spinal cord were examined. The potencies of agonists and antagonists were compared, using extracellular single unit recordings made in spinal cord slices isolated from adult rats. Catecholamines (epinephrine, norepinephrine), phenylethylamines (phenylephrine, methoxamine) and imidazolines (clonidine, oxymetazoline, St587 (2-(2-chloro-5-trifluoromethyl-phenylimino)-imidazoline)) enhanced motoneuron activity. Catecholamines and phenylethylamines elicited maximal responses but imidazolines elicited submaximal responses. The potencies of the agonists were similar to their affinities for alpha1A-adrenoceptors. The alpha1A-adrenoceptor agonist SDZ NVI 085 ((-)-(4aR,10aR)-3,4,4a,5,10,10a-hexahydro-6-methoxy-4-methyl-9-methylthio-2H-naphth[2,3b]-1,4-oxazine) behaved as a partial agonist with a maximal response of about 75% and this response was not inhibited by chloroethylclonidine. Pretreatment with chloroethylclonidine produced a rightward shift of the phenylephrine response curve but caused little reduction in the maximal response. Prazosin, 5-methyl-urapidil, WB4101 (2-([2,6-dimethoxyphenoxyethyl] aminomethyl)-1,4-benzodioxane) and ...Continue Reading

References

Jun 15, 1979·Brain Research·R B McCall, G K Aghajanian
Dec 1, 1989·Journal of Neurochemistry·K M Wilson, K P Minneman
Jul 1, 1966·Acta Physiologica Scandinavica·N E AndénA Lundberg
Jan 16, 1995·European Journal of Pharmacology·A S GoetzD L Saussy
Jan 1, 1995·Pharmacology & Therapeutics·H Ono, H Fukuda
Sep 26, 1996·European Journal of Pharmacology·T WadaH Ono

❮ Previous
Next ❯

Citations

Jun 16, 2004·Behavioural Brain Research·Kenichi MishimaMichihiro Fujiwara
Nov 26, 2002·European Journal of Pharmacology·Paul WellmanJack Nation
Feb 1, 2003·European Journal of Pharmacology·Umit Kazim OzdoğanMika Scheinin
Dec 9, 2000·Autonomic Neuroscience : Basic & Clinical·J T ChengP C Chen
Apr 3, 2008·The Neuroscientist : a Review Journal Bringing Neurobiology, Neurology and Psychiatry·C J HeckmanJenna Schuster
Oct 29, 2009·Cellular and Molecular Life Sciences : CMLS·James R Docherty
Oct 27, 2010·The Journal of Physiology·Koji YashiroEdward C Burgard
Mar 19, 2013·European Journal of Pharmacology·Antti Pertovaara
Jan 25, 2002·The Journal of Comparative Neurology·Ingela HammarElzbieta Jankowska
Feb 23, 2011·Journal of Receptor and Signal Transduction Research·Dianne M Perez, Van A Doze
May 16, 2002·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·Ben J A Janssen, Jos F M Smits
Dec 12, 2017·Biomedical Research·Masahiro KawataniMasahito Kawatani
Apr 4, 2000·Physiological Reviews·J C ReklingJ L Feldman
Apr 11, 2001·American Journal of Physiology. Regulatory, Integrative and Comparative Physiology·M Yoshiyama, W C De Groat
Sep 1, 2001·Pharmacological Research : the Official Journal of the Italian Pharmacological Society·B Civantos Calzada, A Aleixandre de Artiñano
Dec 16, 1998·European Journal of Pharmacology·J R Docherty
Mar 1, 2005·Muscle & Nerve·C J HeckmannDavid J Bennett
Oct 13, 2006·Progress in Neurobiology·Antti Pertovaara
Apr 26, 2011·European Journal of Medicinal Chemistry·Giuseppe RomeoKenneth P Minneman

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adrenergic Receptors: Trafficking

Adrenergic receptor trafficking is an active physiological process where adrenergic receptors are relocated from one region of the cell to another or from one type of cell to another. Discover the latest research on adrenergic receptor trafficking here.